Variation in OSBPL10 is associated with dyslipidemia

Area of Science:

• Genetics and Molecular Biology
• Metabolic Syndrome Research
• Cholesterol Homeostasis

Background:

• The oxysterol hypothesis posits oxysterols mediate cholesterol biosynthesis feedback.
• Oxysterol-binding proteins are crucial in lipid metabolism regulation.
• Previous genome-wide studies identified single-nucleotide polymorphisms (SNPs) in the OSBPL10 gene.

Purpose of the Study:

• To investigate the association between OSBPL10 gene polymorphisms and metabolic syndrome risk factors.
• To analyze the impact of specific OSBPL10 SNPs, including rs2290532 (D254N), on lipid profiles and blood pressure.

Main Methods:

• Selected four single-nucleotide polymorphisms (SNPs) in the OSBPL10 gene for analysis.
• Examined genotype frequencies and their correlation with metabolic risk factors in the Tanno and Sobetsu Study cohort.
• Utilized Hardy-Weinberg equilibrium to validate genotype distributions and multiple regression analysis for independent associations.

Main Results:

• The rs2290532 (D254N) polymorphism was significantly associated with increased low-density lipoprotein (LDL) cholesterol levels.
• Individuals with the CC+CT genotypes for rs2290532 had higher LDL cholesterol compared to the TT genotype.
• The TT genotype for rs2290532 significantly reduced the risk of hyper-LDL cholesterolemia (odds ratio=0.35).

Conclusions:

• The rs2290532 (D254N) polymorphism in the OSBPL10 gene is a potential genetic factor predisposing individuals to hyper-LDL cholesterolemia.
• This SNP is independently associated with LDL cholesterol levels, irrespective of age, sex, or body mass index.
• Further research into OSBPL10's role in cholesterol metabolism is warranted.